BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 16248948)

  • 1. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA.
    Murakami T; Nakamura H; Hori S; Tomoda K; Mitani T; Nakanishi K; Hashimoto T; Tsuda K; Kozuka T; Monden M
    Acta Radiol; 1993 Jul; 34(4):399-403. PubMed ID: 8391291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of MRI manifestations and histopathologic findings in pancreatic head carcinoma in vivo ex vivo].
    Wang DQ; Zeng MS; Shi X; Ji Y; Jin DY; Lou WH; Chen CZ; Li RC; Shen JZ
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):347-51. PubMed ID: 18953833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.
    Yan FH; Zhou KR; Cheng JM; Wang JH; Yan ZP; Da RR; Fan J; Ji Y
    World J Gastroenterol; 2002 Aug; 8(4):658-62. PubMed ID: 12174374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
    Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Kozuka T; Monden M; Wakasa K
    AJR Am J Roentgenol; 1993 Feb; 160(2):295-9. PubMed ID: 8380948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
    Xiao YP; Xiao EH; Luo JG; Bian DJ; Li MQ; He Z; Shang QL; Liang B
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):914-6. PubMed ID: 19173992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
    Huang J; He X; Lin X; Zhang C; Li J
    Chin Med J (Engl); 2000 May; 113(5):446-8. PubMed ID: 11776102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement patterns of small hepatocellular carcinoma shown by dynamic MRI and CT.
    Yan FH; Shen JZ; Li RC; Zeng MS; Wu D; Zhou KR; Yang J; Gong JS; Shi WB
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):420-4. PubMed ID: 14607719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of 3.0T MRI 3D-VIBE dynamic contrast-enhanced in the diagnosis of small hepatocellular carcinomas].
    Wang CS; Duan Q; Xue YJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):905-8. PubMed ID: 19105934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
    Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
    J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of 2D and 3D MRI imaging in the diagnosis of pancreatic carcinoma].
    Wang DQ; Zeng MS; Jin DY; Lou WH; Ji Y; Rao SX; Chen CZ; Li RC
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):216-20. PubMed ID: 17649641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoembolization for unresectable hepatocellular carcinoma in Japan.
    Takayasu K
    Oncology; 2010 Jul; 78 Suppl 1():135-41. PubMed ID: 20616596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation.
    Shinagawa Y; Sakamoto K; Fujimitsu R; Shimakura M; Kora S; Takano K; Yoshimitsu K
    AJR Am J Roentgenol; 2012 Nov; 199(5):1010-7. PubMed ID: 23096173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.